Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Baris Deniz"'
Autor:
Baris Deniz, Apoorva Ambavane, Shuo Yang, Arman Altincatal, Justin Doan, Sumati Rao, M Dror Michaelson
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0215761 (2019)
ObjectiveAdvanced renal cell carcinoma (RCC) is commonly treated with vascular endothelial growth factor or mammalian target of rapamycin inhibitors. As new therapies emerge, interest grows in gaining a deeper understanding of treatment sequences. Re
Externí odkaz:
https://doaj.org/article/d41050ae8b2f4430b56acacde5d9c9ce
Autor:
Baris Deniz, Arman Altincatal, Apoorva Ambavane, Sumati Rao, Justin Doan, Bill Malcolm, M Dror Michaelson, Shuo Yang
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0203406 (2018)
OBJECTIVE:In oncology, extrapolation of clinical outcomes beyond trial duration is traditionally achieved by parametric survival analysis using population-level outcomes. This approach may not fully capture the benefit/risk profile of immunotherapies
Externí odkaz:
https://doaj.org/article/3485163a5e8243b6af12d64d4c95953c
Autor:
Anita J Brogan, Sandra E Talbird, James R Thompson, Jeffrey D Miller, Jaime Rubin, Baris Deniz
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90295 (2014)
To explore the expected long-term health and economic outcomes of telaprevir (TVR) plus peginterferon alfa-2a and ribavirin (PR), a regimen that demonstrated substantially increased sustained virologic response (SVR) compared with PR alone in adults
Externí odkaz:
https://doaj.org/article/78dd742c199944178368b67eb3e5e99a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Tetrahedron 24 November 2016 72(47):7517-7525
Autor:
Ivo, Abraham, Amit, Goyal, Baris, Deniz, Donald, Moran, Marc, Chioda, Karen M, MacDonald, Huan, Huang
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:435-448
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801b8fbaff9fa76e6bf57849b1021aa7
https://doi.org/10.18553/jmcp.2022.21379
https://doi.org/10.18553/jmcp.2022.21379
Autor:
Şeker, Sevil, Barış, Deniz, Arslan, Nevin, Turgut, Yılmaz, Pirinççioğlu, Necmettin, Toğrul, Mahmut
Publikováno v:
In Tetrahedron: Asymmetry 15 March 2014 25(5):411-417
Publikováno v:
In Tetrahedron: Asymmetry 2010 21(15):1893-1899
Autor:
Ivo Abraham, Uchenna Onyekwere, Baris Deniz, Donald Moran, Marc Chioda, Karen MacDonald, Huan Huang
Proliferating hematopoietic stem and progenitor cells (HSPCs) are susceptible to chemotherapy-induced damage, resulting in myelosuppressive adverse events (AEs) such as neutropenia, anemia, and thrombocytopenia that are associated with high health ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a415ad1e3d8a674809563ae91a155082
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:30-31
IntroductionWe reviewed the health technology assessment (HTA) guidelines for therapies targeting orphan conditions in four countries/regions in Asia.MethodsA pragmatic literature search was conducted to identify and review key documents outlining re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::237f949e0aa1167b7f941895438f0851
https://doi.org/10.1017/s0266462320001646
https://doi.org/10.1017/s0266462320001646